drugset
drugset / Trial / NCT05814016

A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery

NCT05814016 ↗

Phase 2 Terminated 41 enrolled Takeda
RandomizedParallel-groupQuadruple-blindOther

Summary

The main aim is to see if danavorexton can help improve people's breathing in the recovery room after abdominal surgery.

Timeline

Start
2023-05-11
Primary completion
2024-09-25
Completion
2024-09-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Danavorexton Small molecule — Intravenous

Indications

obstructive sleep apnea syndrome